Literature DB >> 16517923

Treatment failure due to emergence of resistance to carbapenem during therapy for Shewanella algae bacteremia.

Dong-Min Kim1, Cheol-In Kang, Chang Seop Lee, Hong-Bin Kim, Eui-Chong Kim, Nam Joong Kim, Myoung-Don Oh, Kang-Won Choe.   

Abstract

We describe a case of bacteremia due to imipenem-susceptible Shewanella algae. Despite treatment with imipenem, the patient developed a spinal epidural abscess, from which imipenem-resistant S. algae was isolated. The development of resistance should be monitored when S. algae infection is treated with imipenem, even though the strain is initially susceptible to imipenem.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16517923      PMCID： PMC1393119          DOI： 10.1128/JCM.44.3.1172-1174.2006

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  15 in total

1.  16S ribosomal DNA sequence analysis of a large collection of environmental and clinical unidentifiable bacterial isolates.

Authors:  M Drancourt; C Bollet; A Carlioz; R Martelin; J P Gayral; D Raoult
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

2.  Soft tissue infection and bacteremia caused by Shewanella putrefaciens.

Authors:  Leonardo Pagani; Adolf Lang; Claudio Vedovelli; Oswald Moling; Giovanni Rimenti; Raffaele Pristerà; Peter Mian
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

3.  16S ribosomal DNA amplification for phylogenetic study.

Authors:  W G Weisburg; S M Barns; D A Pelletier; D J Lane
Journal:  J Bacteriol       Date:  1991-01       Impact factor: 3.490

4.  Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections.

Authors:  J P Quinn; E J Dudek; C A DiVincenzo; D A Lucks; S A Lerner
Journal:  J Infect Dis       Date:  1986-08       Impact factor: 5.226

5.  Imipenem resistance in Pseudomonas aeruginosa resulting from diminished expression of an outer membrane protein.

Authors:  K H Büscher; W Cullmann; W Dick; W Opferkuch
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

6.  Primary Shewanella alga septicemia in a patient on hemodialysis.

Authors:  M Iwata; K Tateda; T Matsumoto; N Furuya; S Mizuiri; K Yamaguchi
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

7.  Genetic and biochemical characterization of a chromosome-encoded carbapenem-hydrolyzing ambler class D beta-lactamase from Shewanella algae.

Authors:  Claire Héritier; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

Review 8.  Resistance to imipenem in Pseudomonas aeruginosa: clinical experience and biochemical mechanisms.

Authors:  J P Quinn; A E Studemeister; C A DiVincenzo; S A Lerner
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

Review 9.  In vitro susceptibilities of nonfermentative gram-negative bacilli other than Pseudomonas aeruginosa to 32 antimicrobial agents.

Authors:  R J Fass; J Barnishan
Journal:  Rev Infect Dis       Date:  1980 Nov-Dec

10.  Rapid selection of organisms with increasing resistance on subinhibitory concentrations of norfloxacin in agar.

Authors:  J H Tenney; R W Maack; G R Chippendale
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191
View more
  23 in total

1.  Skin and Soft Tissue Infections due to Shewanella algae - An Emerging Pathogen.

Authors:  Jampala Srinivas; Meera Pillai; Vivek Vinod; R Kavitha Dinesh
Journal:  J Clin Diagn Res       Date:  2015-02-01

2.  Case report and literature review of carbapenem resistant shewanella putrefaciens isolated from ascitic fluid.

Authors:  Frincy Khandelwal Baruah; Rajesh Kumar Grover
Journal:  J Clin Diagn Res       Date:  2014-09-20

3.  In vitro synergism of ciprofloxacin and cefotaxime against nalidixic acid-resistant Salmonella enterica serotypes Paratyphi A and Paratyphi B.

Authors:  Ganesh Prasad Neupane; Dong-Min Kim; Sung Hun Kim; Bok Kwon Lee
Journal:  Antimicrob Agents Chemother       Date:  2010-06-21       Impact factor: 5.191

4.  Relative frequency, characteristics, and antimicrobial susceptibility patterns of Vibrio spp., Aeromonas spp., Chromobacterium violaceum, and Shewanella spp. in the northern territory of Australia, 2000-2013.

Authors:  Gary N McAuliffe; Jann Hennessy; Robert W Baird
Journal:  Am J Trop Med Hyg       Date:  2014-12-29       Impact factor: 2.345

5.  Waterborne Infections in Reunion Island, 2010-2017.

Authors:  Nicolas Allou; Aurélien Soubeyrand; Nicolas Traversier; Romain Persichini; Caroline Brulliard; Dorothée Valance; Olivier Martinet; Sandrine Picot; Olivier Belmonte; Jérôme Allyn
Journal:  Am J Trop Med Hyg       Date:  2018-07-19       Impact factor: 2.345

6.  Shewanella algae Peritonitis in Patients on Peritoneal Dialysis.

Authors:  Malini Shanmuganathan; Bak Leong Goh; Christopher Lim; Zakaria NorFadhlina; Ibrahim Fairol
Journal:  Perit Dial Int       Date:  2016 9-10       Impact factor: 1.756

7.  Purulent pericarditis with greenish pericardial effusion caused by Shewanella algae.

Authors:  Che-Kim Tan; Chih-Cheng Lai; Wei-Khie Kuar; Po-Ren Hsueh
Journal:  J Clin Microbiol       Date:  2008-06-25       Impact factor: 5.948

8.  Genetic and Biochemical Characterization of OXA-535, a Distantly Related OXA-48-Like β-Lactamase.

Authors:  L Dabos; A B Jousset; R A Bonnin; N Fortineau; A Zavala; P Retailleau; B I Iorga; T Naas
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

9.  Shewanella infection of snake bites: a twelve-year retrospective study.

Authors:  Po-Yu Liu; Zhi-Yuan Shi; Chin-Fu Lin; Jin-An Huang; Jai-Wen Liu; Kun-Wei Chan; Kwong-Chung Tung
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

10.  Primary Shewanella algae bacteremia mimicking Vibrio septicemia.

Authors:  Dae Seong Myung; Young-Sun Jung; Seung-Ji Kang; Young A Song; Kyung-Hwa Park; Sook-In Jung; Soo Hyun Kim; Jong-Hee Shin
Journal:  J Korean Med Sci       Date:  2009-11-09       Impact factor: 2.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.